论文部分内容阅读
目的:研究分析糖尿病自主神经病变患者的临床治疗方式。方法:根据该院2012年1月至2013年12月的92例糖尿病患者来进行研究分析,将这些患者分组为对照组和观察组,均有46例,对照组和观察组患者都使用了常规治疗,对患者的血脂血压和血糖进行控制,观察组增加了甲钴胺注射治疗和参麦注射治疗,对照组患者增加了甲钴胺注射治疗,对比分析两组患者的临床自主神经功能改善情况及Vs、RI、PI、血糖、CRP等指标变化情况。结果:完成治疗后,统计表明,观察组患者的临床治疗有效病例是43例,对照组的临床治疗有效病例是36例,两组患者的临床结果存在统计学差异性(χ~2=4.389 5,P=0.036 2)。两组的Vs、RI、PI、血糖、CRP等指标为观察组较为优秀,结果存在统计学差异性(P<0.05)。结论:糖尿病自主神经病变患者临床中接受甲钴胺和参麦注射治疗的效果比较好,患者的临床病变指标改善明显,因此我们推介患者使用甲钴胺和参麦联合注射治疗。
Objective: To study the clinical treatment of patients with diabetic autonomic neuropathy. Methods: According to the hospital from January 2012 to December 2013 in 92 cases of diabetic patients to carry out research and analysis of these patients were divided into control group and observation group, 46 cases, control group and observation group patients were used conventional Treatment, the patient’s blood pressure and blood glucose control, the observation group increased mecobalamin injection and Shenmai injection treatment, the control group was added mecobalamin injection therapy, comparative analysis of two groups of patients with clinical autonomic nervous system function improvement And Vs, RI, PI, blood glucose, CRP and other indicators changes. Results: After the completion of treatment, the statistics showed that the effective clinical observation cases in the observation group were 43 cases and that in the control group was 36 cases. The clinical results of the two groups were statistically different (χ ~ 2 = 4.389 5 , P = 0.036 2). Vs, RI, PI, blood glucose, CRP and other indicators of the two groups were excellent in the observation group, with statistical significance (P <0.05). Conclusion: Patients with diabetic autonomic neuropathy received mecobalamin and shenmai injection in the clinical treatment is better, and patients with clinically significant changes in the index improved significantly, so we recommend the use of mecobalamin and Shenmai injection in patients with combination therapy.